Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q3 2025 Earnings

14AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.65

-0.14

0.37

0.88

Details

Expected EPS

-0.08

Actual EPS

-0.11

Surprise EPS

-0.03

Surprise Percent

+37.5%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.11 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.